Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 337,248 | 228,410 | 102,709 | 377,047 | 291,370 |
| Depreciation Amortization | 65,422 | 42,976 | 21,355 | 83,178 | 62,574 |
| Income taxes - deferred | 2,403 | 3,426 | 3,294 | 1,209 | 12,850 |
| Accounts receivable | -24,451 | -37,699 | -33,421 | -18,401 | -33,041 |
| Accounts payable and accrued liabilities | 1,181 | -4,030 | 699 | -166 | -1,336 |
| Other Working Capital | -125,448 | -117,311 | -99,942 | -91,640 | -126,320 |
| Other Operating Activity | 47,390 | 55,708 | 39,684 | 48,857 | 58,339 |
| Operating Cash Flow | $303,745 | $171,480 | $34,378 | $400,084 | $264,436 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 284,038 | 284,038 |
| PPE Investments | -109,058 | -71,987 | -38,206 | -115,751 | -82,642 |
| Net Acquisitions | -304 | -304 | N/A | -22,500 | -22,500 |
| Purchase Sale Intangibles | -255 | N/A | N/A | -7,185 | -450 |
| Other Investing Activity | -255 | 0 | 0 | -7,185 | -450 |
| Investing Cash Flow | $-109,617 | $-72,291 | $-38,206 | $138,602 | $178,446 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -52,024 | N/A | -240,500 |
| Debt Issued | 100,000 | 100,000 | 100,000 | N/A | N/A |
| Common Stock Issued | 28,739 | 19,653 | 11,551 | 38,201 | 34,595 |
| Common Stock Repurchased | -168,818 | -82,566 | -61,705 | -378,694 | -272,822 |
| Other Financing Activity | -171,941 | -149,356 | -603 | -257,306 | -1,266 |
| Financing Cash Flow | $-212,020 | $-112,269 | $-2,781 | $-597,799 | $-479,993 |
| Exchange Rate Effect | -1,906 | 131 | -569 | -4,768 | -3,687 |
| Beginning Cash Position | 123,794 | 123,794 | 123,794 | 187,675 | 187,675 |
| End Cash Position | 103,996 | 110,845 | 116,616 | 123,794 | 146,877 |
| Net Cash Flow | $-19,798 | $-12,949 | $-7,178 | $-63,881 | $-40,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | 303,745 | 171,480 | 34,378 | 400,084 | 264,436 |
| Capital Expenditure | -109,058 | -71,987 | -38,206 | -115,751 | -82,642 |
| Free Cash Flow | 194,687 | 99,493 | -3,828 | 284,333 | 181,794 |